Pharma Journalist -

AstraZeneca and Daiichi Sankyo Company, Limited (Daiichi Sankyo)’s Enhertu (trastuzumab deruxtecan) has been granted Breakthrough Therapy Designation (BTD) in the US for the treatment…
Read More...

SMi Reports: Registration is open for SMi Group’s 2nd annual Wearable Injectors and Connected Devices Conference taking place in October. SMi’s 2nd annual Wearable Injectors and…
Read More...

Deciphera Pharmaceuticals, Inc. announced the U.S. Food and Drug Administration (FDA) has approved QINLOCK (ripretinib) for the treatment of adult patients with advanced…
Read More...

Takeda China announced that ADCETRIS (brentuximab vedotin) has been officially approved by China’s National Medical Products Administration (NMPA) for use in adult patients with…
Read More...

Boehringer Ingelheim announced the acquisition of Northern Biologics Inc., a wholly owned subsidiary of Northern LP. By acquiring this entity, which focuses on therapeutic antibodies…
Read More...

SMi Reports: New confirmed key speakers and updated agenda for Pharmaceutical Microbiology East Coast, with new dates due to the COVID-19 pandemic, the conference is now taking place on…
Read More...

There is no time like the present to share insights with peers on the new clinical trials being initiated to investigate JAK inhibitor use in patients with COVID-19. This critical…
Read More...

Colorcon, a world leader in the development and supply of film coating systems and excipients, today announces SoteriaRx. This new platform of innovative on-dose technologies and…
Read More...

Recursion announced it has entered into a global licensing agreement with Takeda Pharmaceutical Company Limited (Takeda) to gain rights to TAK-733, a clinical-stage MEK inhibitor, and…
Read More...

Neuraptive Therapeutics, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for its franchise therapeutic product, NTX-001, in the…
Read More...